Evidence map›Paper›PMID 41739434›Full record

ArticleAnnals of nuclear medicine2026

[

Elgin Ozkan, Burak Demir, Guldane Cengiz Seval, Mine Araz, Cigdem Soydal, Irem Mesci, Gulcin Miyase Sonmez, Meral Beksac, Nuriye Ozlem Kucuk

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Elgin OzkanDepartment of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey.ORCID http://orcid.org/0000-0001-8543-0744
Burak DemirDepartment of Nuclear Medicine, Sanliurfa Mehmet Akif Inan Education and Research Hospital, Sanliurfa, Turkey. 4burakfe@gmail.com.ORCID http://orcid.org/0000-0002-0966-9988
Guldane Cengiz SevalDepartment of Hematology, Ankara University Medical School, Ankara, Turkey.ORCID http://orcid.org/0000-0001-9433-2054
Mine ArazDepartment of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey.ORCID http://orcid.org/0000-0001-6467-618X
Cigdem SoydalDepartment of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey.ORCID http://orcid.org/0000-0002-6199-8551
Irem MesciDepartment of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey.ORCID http://orcid.org/0000-0003-4382-2795
Gulcin Miyase SonmezDepartment of Hematology, Ankara University Medical School, Ankara, Turkey.ORCID http://orcid.org/0000-0003-3536-5766
Meral BeksacDepartment of Hematology, Ankara University Medical School, Ankara, Turkey.ORCID http://orcid.org/0000-0003-1797-8657
Nuriye Ozlem KucukDepartment of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey.ORCID http://orcid.org/0000-0002-0717-8261

Funding

Ankara University Scientific Research Projects Coordination Unit THD-2022-2439
6 · The paper itself

Abstract

purposeTo evaluate the prognostic utility of a novel quantitative imaging metric, whole-body metabolic burden (WB-MB), derived from [

methodsIn this prospective, single-center study, 34 patients with biopsy-confirmed MM underwent whole-body [

resultsWB-MB showed significant inverse correlation with hemoglobin and positive correlations with LDH, beta-2 microglobulin (B2M), and serum kappa free light chain levels. No significant associations were observed with platelet count, WBC, or lambda light chains. WB-MB, WB-MB/liver, and WB-MB/aorta were all significantly associated with OS and PFS (p < 0.05), while maximum SUVmean was not. A WB-MB threshold of 164.79 was identified as predictive for PFS. Notably, no deaths occurred in patients with WB-MB < 101 during follow-up.

conclusionWB-MB scoring with [

Indexed as

Bone MarrowMethionineMultiple MyelomaPositron Emission Tomography Computed TomographyAgedCarbon RadioisotopesFemaleHumansMaleMiddle AgedPrognosisProspective StudiesCarbon-11carbon-11 methionineCarbon RadioisotopesMethionine[11C]-Methionine PET/CTHematologyMolecular ImagingMultiple MyelomaOncologyPositron Emission Tomography

Identifiers

PMID41739434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.